Abstract
GABA (30–1000 μM) and the GABA B agonist, (−)baclofen (10–100 μM), but not (+)baclofen, inhibited forskolin-induced cAMP formation in rat spinal cord slices. In contrast, GABA and (−)baclofen failed to enhance the stimulation of cAMP induced by noradrenaline in the same tissue, even though they both increased the response to noradrenaline in cerebral cortex slices. Neonatal capsaicin treatment, which reduces the density of GABA B binding sites in the cord, did not modify the effect of GABA or (−)baclofen on the forskolin-induced elevation of cAMP. (−)Baclofen and GABA inhibition of forskolin effects were insensitive to the GABA B antagonists CGP 35348 and CGP 36742 in the spinal cord. Since CGP 35348 antagonizes baclofen-induced antinociception, it seems unlikely that this effect stems from any change in cAMP within the spinal cord.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
